[1]惠玉洁,朱林凤,李卫民,等.宫颈癌患者血清微小RNA-195、双皮质素样激酶1、鳞状细胞癌抗原表达水平与临床病理特征及预后相关性研究[J].陕西医学杂志,2024,(5):696-699.[doi:DOI:10.3969/j.issn.1000-7377.2024.05.027]
　HUI Yujie,ZHU Linfeng,LI Weimin,et al.Relationship between serum microRNA-195,doublecortin-like kinase 1,squamous cell carcinoma antigen levels and clinicopathological featuresand prognosis in patients with cervical cancer[J].,2024,(5):696-699.[doi:DOI:10.3969/j.issn.1000-7377.2024.05.027]
点击复制

宫颈癌患者血清微小RNA-195、双皮质素样激酶1、鳞状细胞癌抗原表达水平与临床病理特征及预后相关性研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年5期
页码:
696-699
栏目:
临床病理
出版日期:
2024-05-05

文章信息/Info

Title:
Relationship between serum microRNA-195,doublecortin-like kinase 1,squamous cell carcinoma antigen levels and clinicopathological featuresand prognosis in patients with cervical cancer
作者:
惠玉洁; 朱林凤; 李卫民; 赵雪燕; 成叶利
(北京市平谷区医院妇科,北京 101200)
Author(s):
HUI Yujie; ZHU Linfeng; LI Weimin; ZHAO Xueyan; CHENG Yeli
(Department of Gynecology,Beijing Pinggu Hospital,Beijing 101200,China)
关键词:
宫颈癌;  微小RNA-195;  双皮质素样激酶1;  鳞状细胞癌抗原;  临床病理特征;  预后
Keywords:
Cervical cancer;  microRNA-195;  Doublecortin-like kinase 1;  Squamous cell carcinoma antigen;  Clinicopathological features;  Prognosis
分类号:
R 737.33
DOI:
DOI:10.3969/j.issn.1000-7377.2024.05.027
文献标志码:
A
摘要:
目的:探讨宫颈癌患者血清微小RNA-195(miR-195)、双皮质素样激酶1(DCLK1)、鳞状细胞癌抗原(SCC-Ag)水平与临床病理特征及预后的相关性。方法:选取宫颈癌患者72例为观察组,同期体检健康女性60例为对照组,比较两组血清miR-195、DCLK1、SCC-Ag表达水平。采用Spearman法分析宫颈癌患者血清miR-195、DCLK1、SCC-Ag与临床病理特征的相关性,随访3年,记录患者生存情况。采用Cox回归模型分析宫颈癌患者预后的影响因素。结果:观察组血清DCLK1、SCC-Ag水平较对照组升高,miR-195水平较对照组下降(均P<0.05)。血清miR-195水平与淋巴结转移、国际妇产科联盟(FIGO)分期、肿瘤分化程度呈负相关,DCLK1水平与FIGO分期、肿瘤分化程度呈正相关,SCC-Ag水平与肿瘤分化程度、肿瘤直径呈正相关(均P<0.05)。miR-195高表达患者3年生存率高于低表达患者,DCLK1、SCC-Ag高表达患者3年生存率低于低表达患者(均P<0.05)。FIGO分期、分化程度、淋巴结转移、肿瘤直径及血清miR-195、DCLK1、SCC-Ag水平是宫颈癌患者预后的独立影响因素(均P<0.05)。结论:宫颈癌患者血清DCLK1、SCC-Ag水平升高,miR-195水平降低,三者与临床病理特征和预后有关,是宫颈癌患者预后的独立影响因素。
Abstract:
Objective:To investigate the relationship between serum levels of microRNA(miR)-195,doublecortin-like kinase 1(DCLK1),squamous cell carcinoma antigen(SCC-Ag)and clinicopathological features and prognosis in patients with cervical cancer.Methods: Seventy-two patients with cervical cancer were selected as the observation group and 60 healthy women were selected as the control group.The expression levels of serum miR-195,DCLK1 and SCC-Ag of the two groups were compared.The correlation between serum miR-195,DCLK1,SCC-Ag and clinicopathological features of cervical cancer patients was analyzed by Spearman method.The patients were followed up for 3 years and their survival was record.Cox regression model was used to analyze the prognostic factors of patients with cervical cancer.Results: The serum levels of DCLK1 and SCC-Ag in the observation group were higher than those in the control group,and the levels of miR-195 were lower than those in the control group(all P<0.05).Serum miR-195 level was negatively correlated with lymph node metastasis,FIGO stage and tumor differentiation degree,DCLK1 level was positively correlated with FIGO stage and tumor differentiation degree,SCC-Ag level was positively correlated with tumor differentiation degree and tumor diameter(all P<0.05).The 3-year survival rate of patients with high expression of miR-195 was higher than that of patients with low expression,and the 3-year survival rate of patients with high expression of DCLK1 and SCC-Ag was lower than that of patients with low expression(all P<0.05).FIGO stage,degree of differentiation,lymph node metastasis,tumor diameter and serum levels of miR-195,DCLK1 and SCC-Ag were independent factors influencing prognosis of cervical cancer patients(all P<0.05).Conclusion:Serum levels of DCLK1 and SCC-Ag are increased and miR-195 is decreased in patients with cervical cancer,which are related to clinicopathological features and prognosis,and are independent factors influencing prognosis of patients with cervical cancer.

参考文献/References:

[1] 徐红玲,陈旭,肖红燕.宫颈癌组织中叉头框蛋白P3程序性死亡蛋白-1及程序性死亡蛋白-1受体蛋白的表达情况及与临床病理特征的关系[J].中国妇幼保健,2022,37(10):1884-1886.
[2] MAROGA N,MOKOENA T,LEDIBANE N,et al.Profile of human papillomavirus genotypes in breast and oesophageal cancer patients in Pretoria,South Africa[J].S Afr Med J,2023,113(7):49-54.
[3] 王静,袁渊,周敏,等.细胞周期蛋白依赖性激酶亚基2通过干预线粒体功能促进宫颈癌细胞增殖机制研究[J].陕西医学杂志,2022,51(2):136-139.
[4] 向慧敏,李筱,饶琴琴,等.宫颈癌患者血清双皮质素样激酶1、黏蛋白-1、血管生成素-2的表达及临床意义[J].检验医学与临床,2023,20(5):655-659.
[5] 刘坤.鼻内翻性乳头状瘤术后复发影响因素分析[J].陕西医学杂志,2020,49(10):1256-1258.
[6] 蔡月茹,李华林,杨黎,等.SWE联合SCC-Ag定量诊断宫颈癌的临床价值[J].医学影像学杂志,2023,33(2):288-290,304.
[7] 张驰,李奥博,王心怡,等.温阳振衰颗粒调控miR-155/p38MAPK途径减轻大鼠心肌缺血再灌注损伤机制研究[J].陕西中医,2023,44(8):1005-1009.
[8] 顾民华,顾勇.川芎嗪通过miR-34a对氧化型低密度脂蛋白诱导的冠状动脉内皮细胞损伤的保护作用[J].陕西中医,2023,44(9):1169-1172.
[9] 中国抗癌协会妇科肿瘤专业委员会,子宫颈癌诊断与治疗指南(2021年版)[J].中国癌症杂志,2021,31(6):474-489.
[10] TSEGAYE K,HAGOS A,KINDIE H,et al.Evaluation of cervical cancer screening program in Gondar city administration public health facilities,Northwest Ethiopia,2021:Mixed method approach[J].BMC Cancer,2023,23(1):1034.
[11] 吴艳芳,陈蕾.八珍汤加味联合放疗治疗中晚期宫颈癌疗效及对患者细胞免疫水平和营养状态的影响[J].陕西中医,2022,43(8):1052-1055.
[12] 张辉,王成刚,崔志荣,等.miR-195和DLL4蛋白表达与结直肠癌临床病理特征及预后的关系[J].中华普通外科杂志,2021,36(3):169-173.
[13] 张玉虹,孙喜斌,石克威,等.miR-195在子宫内膜癌组织中的表达及其临床意义[J].现代中西医结合杂志,2020,29(35):3929-3931.
[14] 孙恃雷,唐敏,万群,等.微小RNA-195-5p对乳腺癌细胞生长、迁移和侵袭的影响[J].肿瘤,2020,23(2):122-132.
[15] MA J,ZHAO X,SHI L.Circ 003390/eukaryotic translation initiation factor 4A3 promoted cell migration and proliferation in endometrial cancer via vascular endothelial growth factor signaling by miR-195-5p[J].Bioengineered,2022,13(5):11958-11972.
[16] TONY V,SATHYAMURTHY A,RAMIREDDY J K,et al.Role of squamous cell carcinoma antigen in prognostication,monitoring of treatment response,and surveillance of locally advanced cervical carcinoma[J].J Cancer Res Ther,2023,19(5):1236-1240.
[17] QIN L.Study on the preoperative value of serum SCC-Ag in predicting the stromal invasion of cervical squamous cell carcinoma[J].J Cancer Res Clin Oncol,2023,149(11):9167-9171.
[18] 刘亚红,邱育红,王欣.血清鳞状细胞癌抗原(SCC-Ag)、癌胚抗原(CEA)、细胞角蛋白19片段(CYFRA21-1)和HE4联合检测在宫颈癌诊断中的临床价值[J].贵州医药,2022,46(6):843-844,847.
[19] 范晓娜,姚健楠,葛洋,等.DCLK1敲除对食管鳞癌细胞迁移和侵袭能力的影响[J].首都医科大学学报,2019,40(3):417-423.
[20] 王虎明,徐杰,李丽莉.血清DCLK1、lncRNA与肿瘤标志物检测在胃癌早期诊断中的临床分析[J].包头医学,2023,47(2):24-26.
[21] SUREBAN S M,MADHOUN M F,MAY R,et al.Plasma DCLK1 is a marker of hepatocellular carcinoma(HCC):Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism[J].Oncotarget,2015,6(35):37200-37215.
[22] 刘娟,冉立.SCC-Ag在宫颈癌中应用的研究进展[J].现代肿瘤医学,2022,30(2):328-331.
[23] 杨弋弋,周新欢,邹科,等.KISS-1、P16和SCC-Ag在宫颈癌组织中的表达及意义[J].实用癌症杂志,2022,37(10):1578-1582.
[24] 王雯智,郑蕾,李虹.宫颈癌中miR-15b、DCLK1的表达变化及与放疗敏感性的关系[J].河北医药,2020,42(3):330-334.
[25] KWON M S,CHUNG H K,XIAO L,et al.MicroRNA-195 regulates tuft cell function in the intestinal epithelium by altering translation of DCLK1[J].Am J Physiol Cell Physiol,2021,320(6):1042-1054.

相似文献/References:

[1]李 虎,杨 翔,冯凯勋,等.循环肿瘤细胞检测对宫颈癌患者预后的判断价值[J].陕西医学杂志,2021,50(4):492.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.029]
[2]梁 媛,蔡江义,谢 云,等.DNA倍体分析联合血清肿瘤标志物筛查宫颈癌价值研究[J].陕西医学杂志,2021,50(10):1296.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.031]
[3]王 静,袁 渊,周 敏,等.细胞周期蛋白依赖性激酶亚基2通过干预线粒体功能促进宫颈癌细胞增殖机制研究[J].陕西医学杂志,2022,51(2):136.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.002]
　WANG Jing,YUAN Yuan,ZHOU Min,et al.CKS2 promotes the proliferation of cervical cancer cells by interfering with mitochondrial function[J].,2022,51(5):136.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.002]
[4]李玉龙,宗 伟,常素娥,等.微小RNA-195通过靶向BIRC5调控肝癌Hep3B细胞凋亡实验研究[J].陕西医学杂志,2022,51(3):270.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.002]
　LI Yulong,ZONG Wei,CHANG Su'e,et al.Experimental study of miRNA-195 regulating apoptosis of hepatoma Hep3B cells by targeting BIRC5[J].,2022,51(5):270.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.002]
[5]吕瑜玫,陈 丹,朱 桥,等.宫颈癌患者血清微小核糖核酸-381、微小核糖核酸-145水平变化及与临床病理参数相关性分析[J].陕西医学杂志,2023,52(7):925.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.034]
　LYU Yumei,CHEN Dan,ZHU Qiao,et al.Changes of serum microRNA-381 and microRNA-145 levels and their correlation with clinicopathological parameters in patients with cervical cancer[J].,2023,52(5):925.[doi:DOI:10.3969/j.issn.1000-7377.2023.07.034]
[6]袁浩鑫,冯一平,王思雨,等.调控miR-642a-5p表达对宫颈癌HeLa细胞生物学行为的影响及机制研究[J].陕西医学杂志,2023,52(11):1498.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.010]
　YUAN Haoxin,FENG Yiping,WANG Siyu,et al.Effects and mechanism of regulating miR-642a-5p expression on biological behavior of cervical cancer HeLa cells[J].,2023,52(5):1498.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.010]
[7]常娟娟,李太平,康婉英,等.容积旋转调强与调强放疗在宫颈癌放疗中的应用及剂量学、安全性研究[J].陕西医学杂志,2024,(2):194.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.010]
　CHANG Juanjuan,LI Taiping,KANG Wanying,et al.Application,dosimetric and safety analysis of volumetric modulated arc therapy and intensity modulated radiation therapy in radiotherapy of cervical cancer[J].,2024,(5):194.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.010]
[8]季 滢,郑艳莉,韩 云,等.尼美舒利对宫颈癌荷瘤裸鼠移植瘤的影响及机制实验研究[J].陕西医学杂志,2024,(8):1026.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.004]
　JI Ying,ZHENG Yanli,HAN Yun,et al.Effect of nimesulide on cervical cancer tumor-bearing nude mice xenograft and its mechanism[J].,2024,(5):1026.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.004]
[9]冯敏娟,蔡东阁,李 虹.转录因子7-like 2在宫颈癌中表达水平及其与顺铂化疗敏感性关系研究[J].陕西医学杂志,2024,(10):1335.[doi:DOI:10.3969/j.issn.1000-7377.2024.10.008]
　FENG Minjuan,CAI Dongge,LI Hong.Expression level of transcription factor 7-like 2 in cervical cancer and its relationship with cisplatin chemotherapy sensitivity[J].,2024,(5):1335.[doi:DOI:10.3969/j.issn.1000-7377.2024.10.008]
[10]孙长青,李 敏,孟令军,等.生长激素释放肽、褪黑素在年轻宫颈癌患者化疗后血清中的水平变化及其与卵巢储备功能相关性研究[J].陕西医学杂志,2025,54(2):205.[doi:DOI:10.3969/j.issn.1000-7377.2025.02.012]
　SUN Changqing,LI Min,MENG Lingjun,et al.Changes in serum levels of Ghrelin and melatonin in young patients with cervical cancer after chemotherapy and their correlation with ovarian reserve function[J].,2025,54(5):205.[doi:DOI:10.3969/j.issn.1000-7377.2025.02.012]

备注/Memo

备注/Memo:
基金项目:北京市自然科学基金资助项目(7174317); 北京市平谷区医院青年人才科研项目(PGYYQN2022-05)
更新日期/Last Update: 2024-05-06